| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 21, 2026 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$15.00
Est. +111%
|
$7.12 | $7.32 |
Pending
|
$6.06
-14.9%
|
| Aug 06, 2026 |
KORU Medical Systems Inc
KRMD
|
BUY |
$6.00
Est. +67%
|
$3.60 | $4.07 |
Pending
|
$3.70
+2.8%
|
| Aug 04, 2026 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$53.00
Est. +43%
|
$36.94 | $49.57 |
Pending
|
$29.72
-19.5%
|
| Aug 04, 2026 |
Indivior Plc
INDV
|
BUY |
$53.00
Est. +43%
|
$36.94 | $39.74 |
Pending
|
$36.28
-1.8%
|
| Jul 31, 2026 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$20.00
Est. +115%
|
$9.32 | $9.75 |
Pending
|
$6.06
-35.0%
|
| May 04, 2026 |
Celcuity Inc
CELC
|
BUY |
$189.00
Est. +29%
|
$146.24 | $151.02 |
Pending
|
$64.37
-56.0%
|
| Jan 09, 2026 |
Indivior Plc - ADR
INVVY
|
BUY |
$50.00
Est. +129%
|
$21.85 | - | - |
$21.85
0.0%
|
| Oct 31, 2025 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$22.00
Est. +60%
|
$13.76 | $18.31 |
Miss
|
$6.06
-56.0%
|
| Oct 21, 2025 |
Delcath Systems Inc
DCTH
|
BUY |
$20.00
Est. +75%
|
$11.42 | $17.41 |
Miss
|
$20.55
+79.9%
|
| Sep 23, 2025 |
Harrow Inc
HROW
|
BUY |
$64.00
Est. +31%
|
$48.93 | $54.85 |
Miss
|
$30.12
-38.4%
|
| Aug 27, 2025 |
Indivior Plc
INDV
|
BUY |
$34.00
Est. +39%
|
$24.51 | $42.81 |
Target Met
|
$36.28
+48.0%
|
| Aug 27, 2025 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$34.00
Est. +39%
|
$24.51 | $59.68 |
Target Met
|
$29.72
+21.3%
|
| Aug 15, 2025 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$14.00
Est. +64%
|
$8.54 | $13.25 |
Miss
|
$11.62
+36.1%
|
| Jun 16, 2025 |
Neuraxis Inc
NRXS
|
BUY |
$7.00
Est. +178%
|
$2.52 | $9.33 |
Target Met
|
$5.51
+118.7%
|
| May 07, 2025 |
Bioventus Inc - Ordinary Shares - Class A
BVS
|
BUY |
$15.00
Est. +142%
|
$6.20 | $11.25 |
Miss
|
$10.66
+71.9%
|
| Nov 04, 2024 |
Polypid Ltd
PYPD
|
BUY |
$10.00
Est. +200%
|
$3.33 | $3.93 |
Miss
|
$6.26
+88.0%
|
| Oct 28, 2024 |
Eton Pharmaceuticals Inc
ETON
|
BUY |
$15.00
Est. +78%
|
$8.44 | $23.00 |
Target Met
|
$63.93
+657.5%
|
| Oct 18, 2024 |
Xtant Medical Holdings Inc
XTNT
|
BUY |
$1.50
Est. +168%
|
$0.56 | $0.84 |
Miss
|
$0.27
-51.3%
|
| Sep 23, 2024 |
Indivior Plc
INDV
|
BUY |
$20.00
Est. +118%
|
$9.16 | $25.10 |
Target Met
|
$36.28
+296.1%
|
| Sep 23, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$20.00
Est. +118%
|
$9.16 | $47.65 |
Target Met
|
$29.72
+224.5%
|
| Aug 09, 2024 |
Harrow Inc
HROW
|
BUY |
$45.00
Est. +28%
|
$35.25 | $59.23 |
Target Met
|
$30.12
-14.6%
|
| Aug 07, 2024 |
Bioventus Inc - Ordinary Shares - Class A
BVS
|
BUY |
$12.00
Est. +45%
|
$8.25 | $14.37 |
Target Met
|
$10.66
+29.2%
|
| Jul 31, 2024 |
Myomo Inc
MYO
|
BUY |
$7.00
Est. +58%
|
$4.44 | $7.17 |
Precision Hit (±3%)
|
$1.23
-72.3%
|
| Jul 10, 2024 |
Indivior Plc
INDV
|
BUY |
$24.00
Est. +136%
|
$10.19 | $15.88 |
Miss
|
$36.28
+256.0%
|
| Jul 10, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$24.00
Est. +136%
|
$10.19 | $40.28 |
Target Met
|
$29.72
+191.7%
|
| Jun 24, 2024 |
Alimera Sciences Inc.
ALIM
|
SELL |
$5.50
Est. +1%
|
$5.54 | $4.32 (Low) |
Target Met
|
$5.54
0.0%
|
| Jun 21, 2024 |
Harrow Inc
HROW
|
BUY |
$30.00
Est. +51%
|
$19.93 | $59.23 |
Target Met
|
$30.12
+51.1%
|
| May 15, 2024 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$17.00
Est. +132%
|
$7.34 | $7.06 |
Miss
|
$11.62
+58.3%
|
| May 06, 2024 |
Eton Pharmaceuticals Inc
ETON
|
BUY |
$8.00
Est. +116%
|
$3.71 | $18.41 |
Target Met
|
$63.93
+1623.2%
|
| May 01, 2024 |
CVRx Inc
CVRX
|
BUY |
$23.00
Est. +148%
|
$9.27 | $18.50 |
Miss
|
$0.61
-93.4%
|
| Apr 24, 2024 |
Guardant Health Inc
GH
|
BUY |
$28.00
Est. +56%
|
$17.94 | $50.89 |
Target Met
|
$151.84
+746.4%
|
| Apr 03, 2024 |
Indivior Plc
INDV
|
BUY |
$37.00
Est. +73%
|
$21.43 | $15.50 |
Miss
|
$36.28
+69.3%
|
| Apr 03, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$37.00
Est. +73%
|
$21.43 | $40.28 |
Target Met
|
$29.72
+38.7%
|
| Mar 19, 2024 |
Fennec Pharmaceuticals Inc
FENC
|
BUY |
$18.00
Est. +63%
|
$11.01 | $7.06 |
Miss
|
$11.62
+5.5%
|